Financials & SEC Filings | Xeris Biopharma Holdings, Inc.

Proxy Statements

Filing date	Description	Form	View
May 01, 2018	mendment to a previously filed DRS	DRS/A	View HTML 0000950123-18-004001.pdf 0000950123-18-004001.rtf 0000950123-18-004001.xls
Apr 18, 2018	UPLOAD	UPLOAD	0000000000-18-011765.pdf
Mar 21, 2018	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy	DRS	View HTML 0000950123-18-003077.pdf 0000950123-18-003077.rtf 0000950123-18-003077.xls
May 22, 2017		D	View HTML 0001346302-17-000002.pdf 0001346302-17-000002.rtf 0001346302-17-000002.xls
Dec 30, 2016		D/A	View HTML 0001346302-16-000002.pdf 0001346302-16-000002.rtf 0001346302-16-000002.xls
Jan 11, 2016		D	View HTML 0001346302-16-000001.pdf 0001346302-16-000001.rtf 0001346302-16-000001.xls
Sep 29, 2014		D	View HTML 0001346302-14-000001.pdf 0001346302-14-000001.rtf 0001346302-14-000001.xls
Jul 10, 2013		D/A	View HTML 0001346302-13-000002.pdf 0001346302-13-000002.rtf 0001346302-13-000002.xls
Feb 14, 2013		D/A	View HTML 0001346302-13-000001.pdf 0001346302-13-000001.rtf 0001346302-13-000001.xls
Sep 25, 2012		D/A	View HTML 0001346302-12-000002.pdf 0001346302-12-000002.rtf 0001346302-12-000002.xls

Data provided by Kaleidoscope.